SCHEDULE: Law Custodial Inc. Reports 7.8% Stake in Dare Bioscience
Beneficial Ownership Report
Law Custodial Inc. has reported a 7.8% beneficial ownership stake in Dare Bioscience, Inc., holding 1,109,428 ordinary shares.
Summary
- Law Custodial Inc. beneficially owns 1,109,428 ordinary shares of Dare Bioscience, Inc.
- This represents approximately 7.8% of Dare Bioscience, Inc.'s ordinary shares outstanding.
- The percentage is calculated based on 14,289,229 shares outstanding as of November 12, 2025, as filed by the issuer on November 25, 2025.
- Law Custodial Inc. holds sole voting and dispositive power over all 1,109,428 shares.
- Of the total, 631,401 ordinary shares are held as trustee with sole voting and dispositive power.
- The shares were not acquired for the purpose of changing or influencing control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.
Sentiment
Score: 6
Explanation: The filing reports a significant beneficial ownership stake by an institutional investor, which can be viewed positively as a vote of confidence. However, it provides no operational or financial details to assess company performance or future outlook.
Positives
- A significant institutional investor, Law Custodial Inc., has taken a substantial stake, potentially indicating confidence in Dare Bioscience, Inc.'s future prospects.
Future Outlook
No forward-looking statements or guidance are provided in this beneficial ownership report.
Industry Context
This filing indicates a significant institutional investment in Dare Bioscience, Inc., a common occurrence in the biotechnology sector where companies often attract specialized funds and investors interested in long-term growth potential or specific therapeutic areas. Such disclosures provide transparency regarding major shareholder positions.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder may increase investor confidence and provide transparency regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Date used for calculating shares outstanding (14,289,229 shares). |
| 11/25/2025 | Date issuer filed shares outstanding information. |
| 12/22/2025 | Date of event requiring the filing of this statement. |
| 12/23/2025 | Date the Schedule 13G/A was signed and filed. |
Keywords
Dare Bioscience, Law Custodial Inc., Beneficial Ownership, SEC Filing, Schedule 13G, Ordinary Shares, Institutional Investor, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.